TCF7L2 Polymorphisms Influence on Glycemic Control in ICU Patients With Organ Failure
NCT ID: NCT03055169
Last Updated: 2018-05-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
994 participants
OBSERVATIONAL
2012-04-30
2017-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Genetic Effects of rs7903146 and Dietary Intake on Type 2 Diabetes Mellitus Risk in a Healthy Population
NCT04446754
The TCF7L2 Gene: Dietary Prevention of T2DM
NCT03458494
Genetic Variation in CLTCL1 and Whole-body Glucose Control
NCT03998111
Triglyceride Rich Lipoproteins and Platelet Activation in Type 2 Diabetes
NCT03561571
Adipose Tissue Expandability and Type 2 Diabetes
NCT03155412
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
intensive care patients
patients with a least one organ dysfunction
genetic analysis
blood and stools samples
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
genetic analysis
blood and stools samples
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* at least one organ dysfunction
Exclusion Criteria
* pregnant women
* admission less than 48h
18 Years
100 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Lille
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mercedes Jourdain, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
University Hospital, Lille
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU Cote de Nâcre
Caen, , France
Hôpital Roger Salengro, CHRU de Lille
Lille, , France
CH Victor Provot
Roubaix, , France
CHU Charles Nicolle
Rouen, , France
CH Tourcoing
Tourcoing, , France
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Ben Hamou A, Kipnis E, Elbaz A, Bignon A, Nseir S, Tamion F, Du Cheyron D, Jaillette E, Voisin B, Robriquet L, Vanbaelinghem C, Thellier D, Abi Rached H, Jannin A, Duhamel A, Behal H, Machuron F, Espiard S, Preiser JC, Preau S, Pattou F, Jourdain M. Association of transcription factor 7-like 2 gene (TCF7L2) polymorphisms with stress-related hyperglycaemia (SRH) in intensive care and resulting outcomes: The READIAB study. Diabetes Metab. 2020 Jun;46(3):243-247. doi: 10.1016/j.diabet.2019.05.001. Epub 2019 May 20.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2010-A00997-32
Identifier Type: OTHER
Identifier Source: secondary_id
2009_58
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.